ArticleJournal of experimental & clinical cancer research : CR2017

Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma.

Jin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.